Literature DB >> 16616054

Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart.

Andrew J Murray1, Craig A Lygate, Mark A Cole, Carolyn A Carr, George K Radda, Stefan Neubauer, Kieran Clarke.   

Abstract

OBJECTIVE: Many patients with heart failure have whole-body insulin resistance and reduced cardiac fluorodeoxyglucose uptake, but whether these metabolic changes have detrimental effects on the heart is unknown. Here, we tested whether there is a link between insulin resistance and ischemic damage in the chronically infarcted Wistar rat heart, postulating that the heart would have decreased insulin sensitivity, with lower GLUT4 glucose transporter protein levels due to high circulating free fatty acid (FFA) concentrations. A decreased capacity for glucose uptake would lower glycolytic adenosine triphosphate (ATP) production and thereby increase ischemic injury in the infarcted heart. METHODS AND
RESULTS: In vivo left ventricular ejection fractions, measured using echocardiography, were 40% lower in rats 10 weeks after coronary artery ligation than in sham-operated control rats. Insulin-stimulated D[2-3H]glucose uptake was 42% lower in isolated, perfused, infarcted hearts. Myocardial GLUT4 glucose transporter protein levels were 28% lower in the infarcted hearts and correlated negatively with ejection fractions and with fasting plasma FFA concentrations. Compared with controls, chronically infarcted hearts had 46% lower total glucose uptake and three-fold faster ATP hydrolysis rates, measured using phosphorus-31 nuclear magnetic resonance spectroscopy, during 32-min ischemia at 0.4 ml/min/gww. During reperfusion, recovery of left ventricular developed pressure in infarcted hearts was 42% lower than in control hearts.
CONCLUSIONS: Glucose uptake, in response to insulin or ischemia, was lower in the chronically infarcted rat heart and associated with increased circulating FFA concentrations and decreased GLUT4 levels. Thus, infarcted hearts had greater ATP depletion, and consequently incurred greater damage, during ischemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616054     DOI: 10.1016/j.cardiores.2006.02.031

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  23 in total

Review 1.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

2.  Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.

Authors:  Jianru Shi; Wangde Dai; Sharon L Hale; David A Brown; Miao Wang; Xianlin Han; Robert A Kloner
Journal:  Life Sci       Date:  2015-10-06       Impact factor: 5.037

3.  Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding.

Authors:  Jessica M Berthiaume; Martin E Young; Xiaoqin Chen; Tracy A McElfresh; Xin Yu; Margaret P Chandler
Journal:  J Mol Cell Cardiol       Date:  2012-04-20       Impact factor: 5.000

4.  Role of apoptosis signal-regulating kinase-1-c-Jun NH2-terminal kinase-p38 signaling in voltage-gated K+ channel remodeling of the failing heart: regulation by thioredoxin.

Authors:  Kang Tang; Xun Li; Ming-Qi Zheng; George J Rozanski
Journal:  Antioxid Redox Signal       Date:  2010-08-30       Impact factor: 8.401

5.  Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.

Authors:  Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak
Journal:  NMR Biomed       Date:  2020-02-17       Impact factor: 4.044

6.  Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia.

Authors:  Peipei Wang; Joshua M Tate; Steven G Lloyd
Journal:  Life Sci       Date:  2008-10-10       Impact factor: 5.037

7.  Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner.

Authors:  Supachoke Mangmool; Tananat Denkaew; Sarawuth Phosri; Darawan Pinthong; Warisara Parichatikanond; Tsukasa Shimauchi; Motohiro Nishida
Journal:  Mol Endocrinol       Date:  2015-12-11

8.  Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.

Authors:  Que Liu; Christen Anderson; Anatoly Broyde; Clara Polizzi; Rayne Fernandez; Alain Baron; David G Parkes
Journal:  Cardiovasc Diabetol       Date:  2010-11-16       Impact factor: 9.951

Review 9.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study.

Authors:  Marie A Schroeder; Pawel Swietach; Helen J Atherton; Ferdia A Gallagher; Phillip Lee; George K Radda; Kieran Clarke; Damian J Tyler
Journal:  Cardiovasc Res       Date:  2009-12-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.